Q4 2023 Holdings
Filed 2024-02-14 | 104 holdings | $4.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $265.8M | 2,881,567 | 6.5% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $181.8M | 2,661,507 | 4.5% |
| Karuna Therapeutics Inc | COM | 48576A100 | $163.0M | 515,024 | 4.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $157.6M | 1,196,000 | 3.9% |
| Humana Inc(HUM) | COM | 444859102 | $141.9M | 310,000 | 3.5% |
| Penumbra Inc(PEN) | COM | 70975L107 | $135.2M | 537,500 | 3.3% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $130.8M | 3,960,000 | 3.2% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $121.1M | 230,000 | 3.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $113.4M | 2,674,245 | 2.8% |
| Agilon Health Inc(AGL) | COM | 00857U107 | $108.3M | 8,630,000 | 2.7% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $100.7M | 298,500 | 2.5% |
| Idexx Labs Inc(IDXX) | COM | 45168D104 | $99.5M | 179,250 | 2.4% |
| Insulet Corp(PODD) | COM | 45784P101 | $93.7M | 431,750 | 2.3% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $87.2M | 229,250 | 2.1% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $83.9M | 1,754,038 | 2.1% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $83.5M | 1,073,500 | 2.1% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $75.4M | 1,019,500 | 1.9% |
| Dexcom Inc(DXCM) | COM | 252131107 | $74.0M | 596,000 | 1.8% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $71.3M | 1,232,500 | 1.8% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $70.0M | 1,522,893 | 1.7% |
| Align Technology Inc(ALGN) | COM | 016255101 | $60.3M | 220,000 | 1.5% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $57.8M | 1,255,577 | 1.4% |
| Freshpet Inc(FRPT) | COM | 358039105 | $57.5M | 662,500 | 1.4% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $54.7M | 1,851,464 | 1.3% |
| Phreesia Inc(PHR) | COM | 71944F106 | $51.1M | 2,206,700 | 1.3% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $49.4M | 647,300 | 1.2% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $49.1M | 835,776 | 1.2% |
| West Pharmaceutical Svsc Inc(WST) | COM | 955306105 | $48.3M | 137,250 | 1.2% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $47.9M | 2,152,173 | 1.2% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $45.9M | 198,169 | 1.1% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $45.0M | 235,000 | 1.1% |
| Olink Hldg AB | SPONSORED ADS | 680710100 | $42.2M | 1,676,500 | 1.0% |
| Accolade Inc(ACCDEUR) | COM | 00437E102 | $41.9M | 3,485,000 | 1.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $41.4M | 983,301 | 1.0% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $40.5M | 69,500 | 1.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $38.8M | 1,522,238 | 1.0% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $38.5M | 969,646 | 0.9% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $37.5M | 350,750 | 0.9% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $36.5M | 290,000 | 0.9% |
| Pacira Biosciences Inc(PCRX) | COM | 695127100 | $35.6M | 1,055,500 | 0.9% |
| Lifestance Health Group Inc(LFST) | COM | 53228F101 | $35.5M | 4,535,000 | 0.9% |
| Azenta Inc(AZTA) | COM | 114340102 | $33.1M | 507,500 | 0.8% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $31.6M | 327,600 | 0.8% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $31.1M | 1,137,023 | 0.8% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $29.6M | 492,444 | 0.7% |
| Warby Parker Inc(WRBY) | CL A COM | 93403J106 | $28.6M | 2,028,300 | 0.7% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $25.2M | 1,081,064 | 0.6% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $24.9M | 2,771,446 | 0.6% |
| Merus N V | COM | N5749R100 | $24.0M | 872,069 | 0.6% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $23.4M | 1,675,474 | 0.6% |